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Objective: Specialist services for dementia are seeing an increasing number 
of patients. We investigated whether interactional and linguistic features in the 
communication behaviour of patients with memory problems could help 
distinguish between those with problems secondary to neurological disorders 
(ND) and those with Functional Memory Disorder (FMD).  
Methods: In Part 1 of this study, a Diagnostic Scoring Aid (DSA) was 
developed encouraging linguists to provide quantitative ratings for 14 
interactional features. An optimal cut-off differentiating ND and FMD was 
established by applying the DSA to 30 initial patient±doctor memory clinic 
encounters. In Part 2, the DSA was tested prospectively in ten additional 
cases analysed independently by two Conversation Analysts blinded to 
medical information. 
Results:  In part one, the median score of the DSA was +5 in ND and -5 in 
FMD (p<0.001). The optimal numeric DSA cut off (+1) identified patients with 
ND with a sensitivity of 86.7% and a specificity of 100%. In part two, DSA 
scores of rater one correctly predicted 10/10 and those of rater two 9/10 
diagnoses. 
Conclusions This study indicates that interactional and linguistic features can 
help distinguish between patients developing dementia and those with FMD 
and could aid the stratification of patients with memory problems. 
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INTRODUCTION 
Demographic changes have increased pressure on specialist services for 
patients with dementia, causing healthcare professionals and service 
commissioners in many countries to focus on improvements to diagnostic 
pathways for people with memory complaints. In the UK, the National 
'HPHQWLD6WUDWHJ\LGHQWLILHGWKHFORVXUHRIWKHµGHPHQWLDJDS¶the difference 
between the predicted number of people with dementia versus those 
diagnosed as having dementia) as an area of particular concern 1. An audit by 
the Royal College of Psychiatrists found that the number of people assessed 
in specialist clinics with memory concerns increased fourfold between 2010 
and 20132. A further 31% increase was seen from 2013 to 2014.  While the 
µGHPHQWLDJDS¶KDVQDUURZHGwith this increase in activity, it has not been 
reduced at the same rate at which the number of memory clinic referrals has 
risen 3, 4. One reason for this is that the proportion of patients with functional 
memory disorder (FMD) or other non-progressive memory disorders has also 
increased 3, 5, 6. The referral of patients to memory clinics is costly and can 
cause avoidable distress 7, 8. These observations ± combined with studies 
showing that current screening procedures lack sensitivity9  ± suggest that 
case selection for referral to specialist clinics is suboptimal. 
 
It is well recognised that patients exhibit linguistic impairments and deficits in 
spontaneous speech even in the earlier stages of dementia 10, 11. Language 
impoverishment, through grammatical simplification, loss of vocabulary, 
semantic paraphasias, and overuse of semantically empty words, becomes 
progressively evident in dementia, as do impaired semantic processing and 
classification errors 12-15:KLOHWKHDQDO\VLVRISDWLHQWV¶ODQJXDJHPD\
therefore contribute towards identifying those at risk of developing dementia, 
the detection of such language impoverishment i) requires complex linguistic 
analysis, ii) may be diagnostically ambiguous, and iii) does not take account 
of more directly observable conversational or interactional features of 
language. Automated analysis of spontaneous speech could address some of 
the practical problems with the assessment of language in routine practice16, 
17
. However, to date, it remains uncertain how well this method would perform 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  5 
as a screening procedure in clinical situations.  What is more, previous 
approaches have focused on vocal/aural features of speech, abstracted from 
their communicative context. Thus, they would not capture impairments in 
specifically interactional capabilities, that can be detected with methods 
focusing on the co-construction of conversation and which may well be 
particularly early and specific indicators of cognitive complaints secondary to 
neurological disorders (ND).  
 
We aimed to use problems with communication between patients, doctors and 
third parties in medical consultations as a diagnostic tool. Our project was 
inspired by studies demonstrating the potential of Conversation Analysis (CA)-
derived interactional and linguistic observations in the differentiation of 
epilepsy and (non-epileptic) dissociative seizures (DS) 18. Using previously 
described conversational profiles of patients with seizures, CA experts were 
DEOHWRSUHGLFWWKHPHGLFDO³JROGVWDQGDUG´GLDJQRVLVRIHSLOHSV\RU'6ZLWKD
sensitivity and specificity of around 85% 19. 
 
Mirroring the study design pursued in seizure clinics, Conversation Analysts 
have previously described a number of interactional and linguistic features, 
which appeared to distinguish patients with ND from those with FMD in two 
qualitative studies 20, 21. The current paper describes the initial validation and 
assessment of a quantitative Diagnostic Scoring Aid (DSA) guiding analysts to 
rate each doctor-patient encounter on a number of the interactional, topical 
and linguistic features described in these qualitative studies. Part 1 of the 
present study was designed to establish an optimal discriminatory DSA cut-off 
for the distinction of ND and FMD. In Part 2 of this study this numeric cut-off 
was applied prospectively to DSA ratings of clinic interactions with newly 
recruited patients. 
 
METHODS 
 
Participant recruitment and assessment 
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Participant recruitment and assessment have been described in a previous 
article exploring the scope of automated analysis of conversational 
interaction22. Briefly, all participants had been referred to the neurology-led 
memory clinic in Sheffield, UK. Patients are routinely encouraged to bring 
someone along to their memory clinic appointment if possible (accompanying 
person, AP). A member of the study team obtained written informed consent 
prior to the encounter with a neurologist. Participants and AP were only 
consented if they had capacity to make their own decision about participation 
and used English as their first language. Participants whose diagnosis 
remained uncertain and those whose cognitive problems were considered to 
be due to other causes than ND or FMD were excluded. 
 
Participants were investigated and followed up by Consultant Neurologists 
specialising in memory disorders according to clinical need. Participants were 
referred for detailed neuropsychological testing and MRI brain imaging. The 
neuropsychological battery (see Wakefield et al 201423 for details) included 
the Mini Mental State Examination24, tests of short and long term memory 
(verbal and non-verbal)25, abstract reasoning26, 27, attention and executive 
function28, language comprehension, naming by confrontation, category and 
letter fluency29.  
 
All participants were recruited before their first ever appointment in the 
memory clinic. Most patients with ND were in the early disease stages, but 
some already had moderately severe dementia. Diagnoses were reached by 
multidisciplinary consensus; taking into account clinical history, neurological 
examination, neuropsychological scores and neuro-radiological findings. 
$O]KHLPHU¶VGLVHDVHZDVGLDJQRVHGDFFRUGLQJWRWKH1,1&'6-ADRDA 
criteria30. A diagnosis of mixed dementia (AD plus vascular cognitive 
impairment) was made if moderate to severe small vessel ischaemic changes 
or cortical infarctions were present on MRI brain imaging. Vascular Cognitive 
Impairment not demented (VCIND) was used to label those with extensive 
radiological evidence of vascular impairment who, however, did not reach the 
threshold of dementia- i.e. the deterioration in function sufficient to impair 
activities of daily living; these patients were not included in the ND group. The 
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diagnosis of behavioural variant Frontotemporal Dementia (bvFTD) was made 
according to the Rascovsky criteria 31. Mild Cognitive Impairment (MCI) was 
diagnosed according to the Petersen criteria32. We did not use biomarkers for 
amyloid or neurodegeneration (tau or FDG PET) because these tests are 
currently not available at our institution for routine assessment and because 
they are currently not widely used for clinical decision-making in the NHS. 
Initial diagnoses in the ND group were, however, confirmed by clinical follow-
up. 
The diagnosis of FMD was based on the criteria proposed by Schmidtke et al. 
200833 with the exception of the age cut-off of <70 years. We considered this 
criterion overly restrictive because there have been previous reports of cases 
RI µIXQFWLRQDO¶PHPRU\SUREOHPV LQSHRSOHDJHGRYHU34, 35. All participants 
with a Patient Health Questionnaire-9 (PHQ9) score of >15 (indicative of 
current depression) or symptoms of active moderate depression as judged by 
the clinician (and whose memory symptoms may have been due to 
depressive pseudodementia, DPD), were excluded from further analysis. 
Participants were also screened for Generalised Anxiety Disorder using the 
GAD7. However, in keeping with the criteria for the diagnosis of FMD 
proposed by Schmidtke et al., they were not excluded from the study on the 
basis of GAD7 scores. This means that some patients with FMD included in 
this study will have had significant problems with anxiety symptoms other than 
anxiety about memory.  
 
Like those with DPD, participants in whom memory problems were found to 
be due to vascular cognitive impairment (VCI) not related to dementia and 
those for whom the diagnosis remained uncertain were not further analysed. 
Although VCI and DPD are important diagnostic categories, at this early stage 
of development we were keen to test the DSA methodology in only two 
homogeneous diagnostic groups.  
 
Part 1 of this study is based on analyses of the first 15 patients with ND and 
the first 15 patients with FMD whose conversational data were analysable. 
Part 2 is based on the blinded analysis of the consecutive five next patients 
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with ND and next five patients with FMD who agreed to participate in this 
study after the recruitment for Part 1 of this study had been completed.  
 
 
Data preparation for Conversation Analysis (CA) 
Video or audio recordings of the history-WDNLQJSKDVHIURPDSDWLHQW¶VHQWU\
LQWRWKHQHXURORJLVW¶VRIILFHWRWKHstart of cognitive testing) were transcribed 
in detail, using a transcription system capturing the timing of speech (e.g. 
overlaps between speakers, pauses both within and between speaker turns), 
certain intonation and prosodic features of speech (falling/rising intonation, 
loudness, emphasis, sound stretching) 36. 
 
Initial CA approach  
Interactions with patients with ND or FMD were subjected to examination 
using the perspective and methods of CA. CA is a micro-analytic, qualitative 
method, but it is well-suited to combination with statistical measures. It has 
been applied widely to medical interactions in exploratory research37, 38, in 
research aimed at improving the effectiveness of doctor-patient 
communication,39, 40 and in assisting the diagnostic process in other 
conditions 19, 38. It is particularly useful for the identification of detailed aspects 
of language use and communicative practices (e.g. the ways in which patients 
ZLWKHSLOHSV\µQRUPDOLVH¶WKHLUVHL]XUHH[SHULHQFHVZKLOVWSDWLHQWVZLWK
dissociative (nonepileptic) seizures 'FDWDVWURSKLVH¶WKHLUVHL]XUH
descriptions)19.  In their analysis, the CA experts involved in this project 
initially identified the methods individual patients (and accompanying others if 
present) used to describe memory problems to the doctor (see 20, 21 for 
details). 
 
Part 1: Quantitative examination of qualitative findings 
Based on the findings of the initial qualitative analysis 20, 21, we developed a 
diagnostic scoring aid (DSA) to provide a guide for the rating of potentially 
diagnostic features of communication and in order to transform qualitative 
observations into a numeric score (see Table 1). The DSA encourages 
analysts to comment and rate nine separate items. An additional five items 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  9 
focus on triadic features that can only be observed if patients are 
accompanied during their memory clinic appointment. The DSA describes 
findings for each item more in keeping with ND (associated with a score of +1) 
or observations more in keeping with FMD (given a numeric score of -1). 
Items can also be judged as un-ratable and would be given a score of 0. 
Items could be considered un-ratable because the interactional behaviour did 
not take place (for instance because the neurologist had not asked the 
specific question (e.g. ³ZKRLVPRUHFRQFHUQHGDERXWWKHPHPRU\
SUREOHPV"´, the performance provided mixed evidence, or was neither typical 
of that expected from patients with ND nor that of patients with FMD. Free text 
fields are provided for each item allowing the analyst to describe the 
reasoning for their categorical judgement. Finally, the DSA asks the analyst to 
make a qualitative judgement taking account of the whole conversation 
profile.  
 
The applicability of the DSA was initially tested by one CA expert using the 
DSA on the recordings and transcripts of the 30 cases previously analysed in 
a purely qualitative way. The analyst categorised each item as more in 
keeping with ND, more in keeping with FMD or un-rateable. This was 
translated into a numeric score for each item. Finally, item scores were added 
up to produce a total score for each patient. An AUROC statistic was carried 
out based on these numeric ratings to identify an optimal diagnostic cut off 
score.  
 
Part 2: Blinded analysis using a Diagnostic Scoring Aid 
In order to test the discriminatory potential of the DSA, two CA experts 
independently rated an additional ten doctor-patient encounters (five 
consecutive cases in each group with ND and FMD). These cases had not 
been included in the initial qualitative or retrospective quantitative analyses. 
The Conversation Analysts were expected to predict the neurological 
diagnosis in these new cases on the basis of their qualitative analysis of the 
video recordings of the doctor-patient encounter and transcripts of these 
encounters, guided by the DSA. They were also asked to use the DSA to 
produce a numeric assessment score for each participant having provided a 
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score for each DSA feature. The analysts were blinded to all additional 
medical or demographic information about these patients. Analysts were not 
aware of the numeric cut-off calculated by the AUROC statistic at the time of 
this analysis and were encouraged not simply to base their diagnostic 
SUHGLFWLRQRQSDWLHQWV¶QXPHULFVFRUH,QWKHLURYHUDOOTXDOLWDWLYHMXGJHPHQW
this enabled them to place more diagnostic emphasis on particularly 
outstanding features. However, in addition to the number of cases correctly 
diagnosed by their qualitative judgement, we also report the number of cases 
correctly categorised on the basis of the DSA scores using the diagnostic cut-
off calculated in Part 1 of this study.  
 
Statistical analysis 
Routinely collected clinical data on consenting and non-consenting patients 
approached about this study were compared using t-tests to ascertain the 
representativeness of the patient group included. 
 
In Part 1 of this study, the diagnostic potential of individual DSA items was 
H[DPLQHGXVLQJ)LVKHU¶V([DFWWHVWV7KHVLJQLILFDQFHRIGLIIHUHQFHVLQ
median scores of the ND and FMD groups was determined using the Mann-
Whitney U test. An Area Under the Receiver Operated Characteristic Curve 
(AUROC) statistic was used to identify an optimal numeric cut-off for the 
differentiation of ND and FMD. In Part 2 of this study we report Kappa scores 
as a measure of the inter-rater reliability of focussed CA using the DSA.  
 
Ethics 
The study was approved by the NHS Research Ethics Committee (NRES 
Committee Yorkshire & The Humber - South Yorkshire). Ref 12/YH/0205. 
 
RESULTS  
Part 1 
Of 353 patients referred to the specialist memory clinic during the recruitment 
period and of 148 eligible to take part in this study, 36 declined to participate 
and 112 were enrolled (see Figure 1 CONSORT diagram). Three withdrew 
their consent subsequently, leaving 109 who completed the study. There were 
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no significant differences in terms of age, gender, anxiety, depression or ACE-
R scores between those who consented to take part and those who did not, 
suggesting that the participants were representative of the wider population 
served by this memory clinic. There was also no significant difference in terms 
of diagnostic mix between people who consented and people who did not 
consent (see supplementary Table 1). The ND patient group (n=20) 
comprised of eight patients with AD, four with amnestic MCI, two with vascular 
dementia, two with frontotemporal dementia, three mixed AD and vascular 
and one unspecified dementia (without detailed neuropsychology). Figure 1 
also provides more information about participants who were excluded from 
the study. 
 
Clinical details of the patients included in the ND and FMD groups described 
here are provided in Table 2. Two participants out of the twenty with FMD had 
MRI brain scans reported as possible atrophy. They were both followed up; 
One followed up at 24 months was aware that they had been working in a 
very stressful job at time of the first consultation. At follow-up they had 
changed jobs and now had no memory complaints. The second person was 
followed up at 18 months. The Montreal Cognitive Assessment (MoCA) was 
26/30 at follow-up (prior ACE 85 and MoCA 22). They were functioning 
normally in a busy job. Two participants out of twenty cases with ND had 
normal structural scans but one of these had abnormal Single-Photon 
Emission Computed Tomography (SPECT). The other was seen for follow-up 
at 12 months and ACE-R had decreased from 87 to 82, the clinical picture at 
this stage being consistent with AD.  
 
In Part 2 of the study, three out of five FMD cases did not attend for 
neuropsychology testing, hence the missing MMSE scores in table 2. 
However, their ACE-R scores were 87, 96 and 97. Two had entirely normal 
neuroimaging and were discharged. One had an old caudate head infarct and 
on follow-up one year later was still working, managing a team. Repeat ACE-
R was 96 (97 one year earlier). Also in Part 2, one person with ND did not 
have detailed neuropsychological testing. Neuroimaging showed atrophy. On 
follow-up this patient showed significant cognitive impairment.  
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There were no significant differences in demographics, depression, anxiety or 
ACE-R scores between ND participants in Parts 1 and 2 or between FMD 
patients in the two parts of this study. 20 of the 30 participants included in Part 
1, and seven of ten included in Part 2 of this study were accompanied. 
)HDWXUHSDWLHQW¶VKHDGWXUQHQFRXUDJLQJDFFRPSDQ\LQJSHUVRQWRDQVZHU
a question directed at the patient) could not be rated in two of the 
accompanied encounters because participants had only consented to audio 
recording the interaction.  
 
Table 3 VKRZVWKHDQDO\VW¶V'6$UDWLQJVRIWKHLQWHUDFWLRQVLQFOXGHGLQPart 1 
of this study. A more detailed description of the individual items can be found 
on the DSA form (additional web content). The median total score of the first 
nine items of the DSA was +5 in the ND (range +8 to -3) and -5 in the FMD 
group (range 0 to -9, difference p<0.001). 
 
The median total of the five additional items to be rated in accompanied 
encounters was 2 (range +5 to -3) in the ND group and -1 (range 1 to -5) in 
the FMD group (difference p=0.003). The fact that only one of the additional 
items to be rated in accompanied encounters individually yielded a statistically 
significant between-group difference may (at least in part) be explained by the 
relatively small number of accompanied interactions available for analysis.  
 
In view of the fact that the additional item scores for accompanied interactions 
were only available for a subset of the encounters, only the first nine items 
were used for the AUROC analysis and the estimation of a quantitative 
diagnostic threshold. The area under the ROC curve was 0.98 (see Figure 2). 
At the optimal DSA score for the distinction of patients with ND from those 
with FMD of +1 (with DSA score above this threshold suggesting a diagnosis 
of ND) the DSA-derived total score identified patients with ND with a 
sensitivity of 86.7% and a specificity of 100%. 
 
3.4 RESULTS ± PART 2 
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3.4.1 Quantitative scoring using the DSA (blinded results) 
 
Rater 1 was accurate in 10/10 cases, whilst Rater 2 correctly predicted 9/10 
diagnoses on the basis of DSA-guided qualitative analysis (Rater 1 was more 
experienced because of his involvement in Part 1 of the project). The results 
were identical when the linguistic diagnostic prediction was based on the 
numeric DSA scores. The case misdiagnosed by Rater 2 as FMD (when the 
ultimate medical diagnosis was ND) attracted the lowest score Rater 1 gave 
to any of the patients assessed as having ND (+4) and the highest score 
Rater 2 gave to any patients thought to have FMD (-1). This suggests that the 
patient misdiagnosed by Rater 2 had an objectively ambiguous conversational 
profile, posing a particular discriminatory challenge. The differences in the two 
UDWHUV¶GLDJQRVWLFSUHGLFWLRQZDVEDVHGRQDVLQJOHFRPSOHWHO\GLVFRUGDQW
judgment of DSA item 4 (ratings 1 vs. -1) and on non-concordant decisions (0 
vs. 1 or 0 vs. -1) on DSA items 3, 7, 9, 13 and 14 (see Table 4 for further DSA 
scoring details).  
 
 
3.4.2 Inter-rater reliability of the DSA 
 
,QWHUPVRIWKHILQDOGLDJQRVLVHLWKHUEDVHGRQWKHWZRUDWHUV¶TXDOLWDWLYH
judgements or the quantitative procedure using the diagnostic cut-off derived 
from the AUROC analysis), the raters agreed in 9/10 cases. The Kappa value 
for the DSA procedure as a whole was therefore 0.8 (SE of Kappa = 0.19, 
95% confidence interval 0.44 to 1.0) suggesting 'very good' inter-rater 
reliability. We also looked at the inter-rater reliability of the 123 individual +1, 0 
or -1 ratings from Part 2 of this study. Both ratings were fully concordant for 
87 numeric scores (the scores from raters 1 and 2 were 1/1, 0/0 or -1/-1), non-
concordant for 30 and discordant for 6. This means that both raters agreed on 
70.7% of the observations when agreement on 33.8% of the ratings would 
have been expected by chance.  The Kappa value for all 123 DSA-based 
ratings combined was 0.56 (SE of Kappa = 0.06, 95% confidence interval 
0.44 to 0.68), consistent with 'moderate' inter-UDWHUDJUHHPHQW7KHWZRUDWHUV¶
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scores for each item assessed in part 2 of the study and the Kappa-values of 
each individual item are shown in table 3. 
 
Discussion 
Our previous qualitative work has demonstrated that it is possible to describe 
characteristic conversational profiles of patients describing cognitive problems 
due to ND or FMD based on their interactional and linguistic contributions to 
initial encounters in a memory clinic20, 21. However, in these descriptive 
studies, the conversation analysts who analysed video- and audio recordings 
of memory clinic encounters between neurologists, patients and (sometimes) 
accompanying persons were DOZD\VDZDUHRIWKHSDWLHQWV¶PHdical diagnoses 
during the analytic process. The present study is the first to demonstrate that 
these linguistic and interactional features can be used diagnostically to predict 
diagnoses of ND or FMD made on the basis of standard medical criteria. 
What is more, we show that qualitative assessments can be structured and 
likely medical diagnoses formulated using a Diagnostic Scoring Aid with a 
numeric diagnostic cut-off.  The fact that the linguistic raters involved in this 
study had no expertise in the medical assessment of patients presenting with 
memory problems, together with the relatively high level of agreement 
between the two raters, suggests that the raters did not base their diagnostic 
predictions on an ill-defined hunch but on robust and objectifiable interactional 
observations. 
  
The correct classification of 9/10 by one rater and 10/10 by a second 
independent rater, and the very good inter-rater reliability of the DSA-guided 
procedure as a whole, suggest that the addition of the structured observation 
of interactional features can make a significant contribution to screening 
processes for ND. Importantly, this is one of the few studies of cognitive 
VFUHHQLQJµWRROV¶WRLQFOXGHSDUWLFLSDQWVZLWK)0D; most previous studies 
compared patients with memory impairment with healthy controls. The 
inclusion of a group of patients with memory complaints but no neurological 
disorder adds ecological validity to our findings. Compared to other studies 
set in clinical situations (such as a study exploring the screening potential of 
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the 6CIT brief cognitive test in primary care) our approach appears to have 
greater reliability and validity 9. 
 
Interactional and linguistic observations may increase the confidence of non-
expert clinicians to diagnose clear cases of FMD, enabling them to treat 
patients in primary care or to refer them on to services providing appropriate 
treatment for functional neurological disorders.  Importantly, the interactional 
and linguistic observations contributing to the diagnosis of FMD may allow 
clinicians to provide more effective reassurance by allowing them to 
demonstrate to patients that they are displaying good memory function in 
interaction. It should be possible for clinicians to pick up these features during 
routine clinic encounters. Previous studies in patients presenting with epileptic 
or dissociative (non-epileptic) seizures have demonstrated that doctors can 
learn to change their history-WDNLQJVW\OHWRRSWLPLVHSDWLHQWV¶RSSRUWXQLWLHVWR
demonstrate particular conversational behaviours and to make diagnostically 
useful interactional observations as they take a paWLHQW¶VKLVWRU\41. The DSA 
developed here could be modified and used in similar studies investigating 
whether clinicians can be trained to identify features, which have diagnostic 
value while talking to patients with memory problems.  
 
This study has a number of limitations. First and foremost, we were only able 
to explore the potential of CA as a tool capable of predicting medical 
diagnoses in the setting of initial memory clinic encounters in a modest 
number of patients. Whilst the consecutive recruitment and the levels of 
statistical significance in between-group tests on a range of separate 
conversational features observed even in such a small patient group make it 
unlikely that our findings are spurious, it would be desirable to replicate our 
findings in a larger and more diverse group of patients. One particular 
limitation of our findings in this regard is that we excluded patients with 
depression and those with VCI from this first quantitative study of our method. 
These are important differential diagnoses, which will need to be picked up by 
screening procedures. Future larger studies will need to demonstrate that the 
inclusion of interactional and linguistic observations can contribute to 
screening or stratification procedures in which patients with these problems 
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are allocated to the correct management pathways. We also recognised that 
the ND and FMD groups in this study were not age-matched since those with 
ND were significantly older. This is not surprising as the biggest risk factor for 
ND is increasing age. However as younger patients with memory concerns 
are increasingly referred to specialist memory clinics it is important to include 
and compare all age groups in studies of this nature. Furthermore the mean 
MMSE score of the ND group was lower than that of the FMD group (20.4 
versus 28.2), reflecting the relatively late stage in the development of 
cognitive disorders at which patients are currently first referred to specialist 
services. Only four of the patients in the ND groups had MCI. An optimal 
screening tool for the earliest stages of ND would need to be capable of 
picking up patients with MCI and near normal MMSE scores). This means that 
confirmatory studies capturing more patients at an earlier stage of ND will be 
required before the method described here can be embedded in screening 
procedures. The MMSE scores of the MCI patients included in this study were 
just above the standard cut-off score of 23 for this test, indicating that, 
although unimpaired in their activities of daily living, they already had 
extensive global cognitive impairment. We do not know how effective this tool 
will be at distinguishing MCI from FMD. Because a clinical diagnosis of MCI 
refers to a very heterogeneous symptom profile, the distinction between MCI 
and FMD might be difficult and will require larger number of participants, 
along with prospective follow-up to investigate whether it can predict those 
who are at high risk of developing AD or other dementias. 
 
 
We have only studied native English speakers; findings may have been 
different in patients speaking other languages or those using English as a 
second language. Although several different doctors were involved in the 
clinic conversations studied here, it would also be important to test this 
procedure in different clinical settings (for instance in community-based 
clinics, during home visits and in elderly-care settings). The fact that the ND 
group included patients with memory problems of different aetiologies should 
not be considered a weakness of this study. Although it is likely the method 
employed in this study could also be deployed to identify interactional 
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differences between different ND VXFKDV$O]KHLPHU¶VGLVHDVHRU
frontotemporal dementia) the fact that we were able to distinguish clearly 
between patients with a range of ND and those with FMD demonstrates its 
potential for screening or stratifying patient management.  
 
We did not have access to investigations confirming clinical diagnosis with 
tests documenting the presence of amyloid or tau (PET or cerebrospinal 
studies), but this reflects current NICE guidelines 
(http://www.nice.org.uk/guidance/CG42) and our µPHGLFDO¶diagnoses were 
based on multidisciplinary assessment by experts including detailed 
neuropsychological testing and structural brain imaging as well as clinical 
follow up.  
 
Future studies will need to demonstrate how much diagnostic value the 
observation of interactional features can add to conventional brief cognitive 
screening tools. A combined approach with an automated low cost, high-
speed system to analyse speech will require the use of technology rather than 
Conversation Analysts. One way in which the research described here can be 
taken forward involves the computerised analysis of speech which has shown 
some promise in distinguishing AD, MCI and healthy controls16. Early 
indications are that computerised speech analysis and machine learning 
algorithms can also be used to produce an automated system to pick up and 
evaluate the sort of interactional observations described here and can 
discriminate between ND and FMD 22. 
 
More immediately, the findings described here can be used in the training of 
clinicians working with patients with memory problems.  
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Figure 1. CONSORT diagram showing recruitment to study. FMD- Functional 
Memory Disorder; DPD- Depressive Pseudo Dementia; ND- memory 
problems secondary to neurological disorders (ND) ± this includes 
neurodegenerative dementias and mild cognitive impairment due to likely 
underlying neurodegenerative aetiology. 
 
Figure 2: Area under the Receiver Operator Characteristic Curve  
A ROC curve was constructed for the sample of 15 ND and 15 FMD cases. 
 
Table 1 Diagnostic Scoring Aid (DSA) 
For each interactional feature scores range between 1 and -1 (1: in favour of 
ND; 0: undecided or unable to rate; -1: in favour of FMD). There are 9/14 
(unaccompanied/accompanied) items to score, so the maximum score is 9/14 
(unaccompanied/accompanied) and minimum score -9/-14 
(unaccompanied/accompanied). A high score corresponds to a stereotypical 
ND description; a low score to a stereotypical FMD description. 
 
Supplementary Table 1 Comparison of patients eligible for participation in 
the study who did and did not consent to have their clinic interaction recorded 
and analysed. 
 
There is no significant difference in demographics or test scores between the 
people who consented and the SHRSOHZKRGLGQRWFRQVHQW$GGHQEURRNH¶V
Cognitive Examination; Patient Health Questionnaire-9 PHQ9- Generalised 
Anxiety Disorder scale 7 GAD7 
 
Table 2 Demographic and neuropsychological results 
ACE-5$GGHQEURRNH¶V&RJQLWLYH([DPLQDWLRQ006(0LQL0HQWDOState 
Examination. PHQ9- Patient Health Questionnaire 9 item depression scale. 
GAD7General Anxiety Disorder 7-item Scale  CF- Confrontational Naming. 
VPA- Verbal Paired Associates, P&PT-3\UDPLG	3DOP7UHHV5H\¶V&)- 
Rey's Complex Figure, SF- Semantic Fluency, PF - Phonemic Fluency, DS -
Digit Span, VCA- Visuoconstructive Apraxia, TT-Token task, PM - Prose 
Memory. * 3 missing scores. + 1 missing score. # 
Three missing scores from ND group (2 due to different protocol and one 
participants from part 2). Three missing scores from FMD group due to not 
attending appointments. Twenty participants with ND; comprised eight with 
AD, four with amnestic MCI, two 2 with vascular dementia, two with fronto 
temporal dementia, three with mixed AD and vascular and one unspecified 
dementia (without detailed neuropsychology).  
 
 
Table 3: Diagnostic Scoring Aid (DSA) results 
Profiles of 30 patients attending a specialist clinic with memory secondary to 
neurological disorders (ND) ± this includes neurodegenerative dementias and 
mild cognitive impairment due to likely underlying neurodegenerative 
aetiology or functional memory disorder (FMD).  3a: Items rated in all 
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encounters / 3b: Items only rated in encounters also involving an 
accompanying person (AP). 
For a full description of the items see supplementary appendix. Some items 
were unratable because a particular question was nRWDVNHGHJ³ZKRLVPRVW
FRQFHUQHG"´ 
 
 
Table 4 Diagnostic Scoring Aid (DSA) results of blinded analysis. 
Two independent linguistic raters (L1 and L2) of interactions with five patients 
with a medical diagnosis of FMD (5a) and five patients with medical diagnosis 
of ND (5b). 
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Objective: Specialist services for dementia are seeing an increasing number 
of patients. We investigated whether interactional and linguistic features in the 
communication behaviour of patients with memory problems could help 
distinguish between those with problems secondary to neurological disorders 
(ND) and those with Functional Memory Disorder (FMD).  
Methods: In Part 1 of this study, a Diagnostic Scoring Aid (DSA) was 
developed encouraging linguists to provide quantitative ratings for 14 
interactional features. An optimal cut-off differentiating ND and FMD was 
established by applying the DSA to 30 initial patient±doctor memory clinic 
encounters. In Part 2, the DSA was tested prospectively in ten additional 
cases analysed independently by two Conversation Analysts blinded to 
medical information. 
Results:  In part one, the median score of the DSA was +5 in ND and -5 in 
FMD (p<0.001). The optimal numeric DSA cut off (+1) identified patients with 
ND with a sensitivity of 86.7% and a specificity of 100%. In part two, DSA 
scores of rater one correctly predicted 10/10 and those of rater two 9/10 
diagnoses. 
Conclusions This study indicates that interactional and linguistic features can 
help distinguish between patients developing dementia and those with FMD 
and could aid the stratification of patients with memory problems. 
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INTRODUCTION 
Demographic changes have increased pressure on specialist services for 
patients with dementia, causing healthcare professionals and service 
commissioners in many countries to focus on improvements to diagnostic 
pathways for people with memory complaints. In the UK, the National 
'HPHQWLD6WUDWHJ\LGHQWLILHGWKHFORVXUHRIWKHµGHPHQWLDJDS¶the difference 
between the predicted number of people with dementia versus those 
diagnosed as having dementia) as an area of particular concern 1. An audit by 
the Royal College of Psychiatrists found that the number of people assessed 
in specialist clinics with memory concerns increased fourfold between 2010 
and 20132. A further 31% increase was seen from 2013 to 2014.  While the 
µGHPHQWLDJDS¶KDVQDUURZHGwith this increase in activity, it has not been 
reduced at the same rate at which the number of memory clinic referrals has 
risen 3, 4. One reason for this is that the proportion of patients with functional 
memory disorder (FMD) or other non-progressive memory disorders has also 
increased 3, 5, 6. The referral of patients to memory clinics is costly and can 
cause avoidable distress 7, 8. These observations ± combined with studies 
showing that current screening procedures lack sensitivity9  ± suggest that 
case selection for referral to specialist clinics is suboptimal. 
 
It is well recognised that patients exhibit linguistic impairments and deficits in 
spontaneous speech even in the earlier stages of dementia 10, 11. Language 
impoverishment, through grammatical simplification, loss of vocabulary, 
semantic paraphasias, and overuse of semantically empty words, becomes 
progressively evident in dementia, as do impaired semantic processing and 
classification errors 12-15:KLOHWKHDQDO\VLVRISDWLHQWV¶ODQJXDJHPD\
therefore contribute towards identifying those at risk of developing dementia, 
the detection of such language impoverishment i) requires complex linguistic 
analysis, ii) may be diagnostically ambiguous, and iii) does not take account 
of more directly observable conversational or interactional features of 
language. Automated analysis of spontaneous speech could address some of 
the practical problems with the assessment of language in routine practice16, 
17
. However, to date, it remains uncertain how well this method would perform 
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as a screening procedure in clinical situations.  What is more, previous 
approaches have focused on vocal/aural features of speech, abstracted from 
their communicative context. Thus, they would not capture impairments in 
specifically interactional capabilities, that can be detected with methods 
focusing on the co-construction of conversation and which may well be 
particularly early and specific indicators of cognitive complaints secondary to 
neurological disorders (ND).  
 
We aimed to use problems with communication between patients, doctors and 
third parties in medical consultations as a diagnostic tool. Our project was 
inspired by studies demonstrating the potential of Conversation Analysis (CA)-
derived interactional and linguistic observations in the differentiation of 
epilepsy and (non-epileptic) dissociative seizures (DS) 18. Using previously 
described conversational profiles of patients with seizures, CA experts were 
DEOHWRSUHGLFWWKHPHGLFDO³JROGVWDQGDUG´GLDJQRVLVRIHSLOHSV\RU'6ZLWKD
sensitivity and specificity of around 85% 19. 
 
Mirroring the study design pursued in seizure clinics, Conversation Analysts 
have previously described a number of interactional and linguistic features, 
which appeared to distinguish patients with ND from those with FMD in two 
qualitative studies 20, 21. The current paper describes the initial validation and 
assessment of a quantitative Diagnostic Scoring Aid (DSA) guiding analysts to 
rate each doctor-patient encounter on a number of the interactional, topical 
and linguistic features described in these qualitative studies. Part 1 of the 
present study was designed to establish an optimal discriminatory DSA cut-off 
for the distinction of ND and FMD. In Part 2 of this study this numeric cut-off 
was applied prospectively to DSA ratings of clinic interactions with newly 
recruited patients. 
 
METHODS 
 
Participant recruitment and assessment 
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Participant recruitment and assessment have been described in a previous 
article exploring the scope of automated analysis of conversational 
interaction22. Briefly, all participants had been referred to the neurology-led 
memory clinic in Sheffield, UK. Patients are routinely encouraged to bring 
someone along to their memory clinic appointment if possible (accompanying 
person, AP). A member of the study team obtained written informed consent 
prior to the encounter with a neurologist. Participants and AP were only 
consented if they had capacity to make their own decision about participation 
and used English as their first language. Participants whose diagnosis 
remained uncertain and those whose cognitive problems were considered to 
be due to other causes than ND or FMD were excluded. 
 
Participants were investigated and followed up by Consultant Neurologists 
specialising in memory disorders according to clinical need. Participants were 
referred for detailed neuropsychological testing and MRI brain imaging. The 
neuropsychological battery (see Wakefield et al 201423 for details) included 
the Mini Mental State Examination24, tests of short and long term memory 
(verbal and non-verbal)25, abstract reasoning26, 27, attention and executive 
function28, language comprehension, naming by confrontation, category and 
letter fluency29.  
 
All participants were recruited before their first ever appointment in the 
memory clinic. Most patients with ND were in the early disease stages, but 
some already had moderately severe dementia. Diagnoses were reached by 
multidisciplinary consensus; taking into account clinical history, neurological 
examination, neuropsychological scores and neuro-radiological findings. 
$O]KHLPHU¶VGLVHDVHZDVGLDJQRVHGDFFRUGLQJWRWKH1,1&'6-ADRDA 
criteria30. A diagnosis of mixed dementia (AD plus vascular cognitive 
impairment) was made if moderate to severe small vessel ischaemic changes 
or cortical infarctions were present on MRI brain imaging. Vascular Cognitive 
Impairment not demented (VCIND) was used to label those with extensive 
radiological evidence of vascular impairment who, however, did not reach the 
threshold of dementia- i.e. the deterioration in function sufficient to impair 
activities of daily living; these patients were not included in the ND group. The 
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diagnosis of behavioural variant Frontotemporal Dementia (bvFTD) was made 
according to the Rascovsky criteria 31. Mild Cognitive Impairment (MCI) was 
diagnosed according to the Petersen criteria32. We did not use biomarkers for 
amyloid or neurodegeneration (tau or FDG PET) because these tests are 
currently not available at our institution for routine assessment and because 
they are currently not widely used for clinical decision-making in the NHS. 
Initial diagnoses in the ND group were, however, confirmed by clinical follow-
up. 
The diagnosis of FMD was based on the criteria proposed by Schmidtke et al. 
200833 with the exception of the age cut-off of <70 years. We considered this 
criterion overly restrictive because there have been previous reports of cases 
RI µIXQFWLRQDO¶PHPRU\SUREOHPV LQSHRSOHDJHGRYHU34, 35. All participants 
with a Patient Health Questionnaire-9 (PHQ9) score of >15 (indicative of 
current depression) or symptoms of active moderate depression as judged by 
the clinician (and whose memory symptoms may have been due to 
depressive pseudodementia, DPD), were excluded from further analysis. 
Participants were also screened for Generalised Anxiety Disorder using the 
GAD7. However, in keeping with the criteria for the diagnosis of FMD 
proposed by Schmidtke et al., they were not excluded from the study on the 
basis of GAD7 scores. This means that some patients with FMD included in 
this study will have had significant problems with anxiety symptoms other than 
anxiety about memory.  
 
Like those with DPD, participants in whom memory problems were found to 
be due to vascular cognitive impairment (VCI) not related to dementia and 
those for whom the diagnosis remained uncertain were not further analysed. 
Although VCI and DPD are important diagnostic categories, at this early stage 
of development we were keen to test the DSA methodology in only two 
homogeneous diagnostic groups.  
 
Part 1 of this study is based on analyses of the first 15 patients with ND and 
the first 15 patients with FMD whose conversational data were analysable. 
Part 2 is based on the blinded analysis of the consecutive five next patients 
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with ND and next five patients with FMD who agreed to participate in this 
study after the recruitment for Part 1 of this study had been completed.  
 
 
Data preparation for Conversation Analysis (CA) 
Video or audio recordings of the history-WDNLQJSKDVHIURPDSDWLHQW¶VHQWU\
LQWRWKHQHXURORJLVW¶VRIILFHWRWKHstart of cognitive testing) were transcribed 
in detail, using a transcription system capturing the timing of speech (e.g. 
overlaps between speakers, pauses both within and between speaker turns), 
certain intonation and prosodic features of speech (falling/rising intonation, 
loudness, emphasis, sound stretching) 36. 
 
Initial CA approach  
Interactions with patients with ND or FMD were subjected to examination 
using the perspective and methods of CA. CA is a micro-analytic, qualitative 
method, but it is well-suited to combination with statistical measures. It has 
been applied widely to medical interactions in exploratory research37, 38, in 
research aimed at improving the effectiveness of doctor-patient 
communication,39, 40 and in assisting the diagnostic process in other 
conditions 19, 38. It is particularly useful for the identification of detailed aspects 
of language use and communicative practices (e.g. the ways in which patients 
ZLWKHSLOHSV\µQRUPDOLVH¶WKHLUVHL]XUHH[SHULHQFHVZKLOVWSDWLHQWVZLWK
dissociative (nonepileptic) seizures 'FDWDVWURSKLVH¶WKHLUVHL]XUH
descriptions)19.  In their analysis, the CA experts involved in this project 
initially identified the methods individual patients (and accompanying others if 
present) used to describe memory problems to the doctor (see 20, 21 for 
details). 
 
Part 1: Quantitative examination of qualitative findings 
Based on the findings of the initial qualitative analysis 20, 21, we developed a 
diagnostic scoring aid (DSA) to provide a guide for the rating of potentially 
diagnostic features of communication and in order to transform qualitative 
observations into a numeric score (see Table 1). The DSA encourages 
analysts to comment and rate nine separate items. An additional five items 
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focus on triadic features that can only be observed if patients are 
accompanied during their memory clinic appointment. The DSA describes 
findings for each item more in keeping with ND (associated with a score of +1) 
or observations more in keeping with FMD (given a numeric score of -1). 
Items can also be judged as un-ratable and would be given a score of 0. 
Items could be considered un-ratable because the interactional behaviour did 
not take place (for instance because the neurologist had not asked the 
specific question (e.g. ³ZKRLVPRUHFRQFHUQHGDERXWWKHPHPRU\
SUREOHPV"´, the performance provided mixed evidence, or was neither typical 
of that expected from patients with ND nor that of patients with FMD. Free text 
fields are provided for each item allowing the analyst to describe the 
reasoning for their categorical judgement. Finally, the DSA asks the analyst to 
make a qualitative judgement taking account of the whole conversation 
profile.  
 
The applicability of the DSA was initially tested by one CA expert using the 
DSA on the recordings and transcripts of the 30 cases previously analysed in 
a purely qualitative way. The analyst categorised each item as more in 
keeping with ND, more in keeping with FMD or un-rateable. This was 
translated into a numeric score for each item. Finally, item scores were added 
up to produce a total score for each patient. An AUROC statistic was carried 
out based on these numeric ratings to identify an optimal diagnostic cut off 
score.  
 
Part 2: Blinded analysis using a Diagnostic Scoring Aid 
In order to test the discriminatory potential of the DSA, two CA experts 
independently rated an additional ten doctor-patient encounters (five 
consecutive cases in each group with ND and FMD). These cases had not 
been included in the initial qualitative or retrospective quantitative analyses. 
The Conversation Analysts were expected to predict the neurological 
diagnosis in these new cases on the basis of their qualitative analysis of the 
video recordings of the doctor-patient encounter and transcripts of these 
encounters, guided by the DSA. They were also asked to use the DSA to 
produce a numeric assessment score for each participant having provided a 
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score for each DSA feature. The analysts were blinded to all additional 
medical or demographic information about these patients. Analysts were not 
aware of the numeric cut-off calculated by the AUROC statistic at the time of 
this analysis and were encouraged not simply to base their diagnostic 
SUHGLFWLRQRQSDWLHQWV¶QXPHULFVFRUH,QWKHLURYHUDOOTXDOLWDWLYHMXGJHPHQW
this enabled them to place more diagnostic emphasis on particularly 
outstanding features. However, in addition to the number of cases correctly 
diagnosed by their qualitative judgement, we also report the number of cases 
correctly categorised on the basis of the DSA scores using the diagnostic cut-
off calculated in Part 1 of this study.  
 
Statistical analysis 
Routinely collected clinical data on consenting and non-consenting patients 
approached about this study were compared using t-tests to ascertain the 
representativeness of the patient group included. 
 
In Part 1 of this study, the diagnostic potential of individual DSA items was 
H[DPLQHGXVLQJ)LVKHU¶V([DFWWHVWV7KHVLJQLILFDQFHRIGLIIHUHQFHVLQ
median scores of the ND and FMD groups was determined using the Mann-
Whitney U test. An Area Under the Receiver Operated Characteristic Curve 
(AUROC) statistic was used to identify an optimal numeric cut-off for the 
differentiation of ND and FMD. In Part 2 of this study we report Kappa scores 
as a measure of the inter-rater reliability of focussed CA using the DSA.  
 
Ethics 
The study was approved by the NHS Research Ethics Committee (NRES 
Committee Yorkshire & The Humber - South Yorkshire). Ref 12/YH/0205. 
 
RESULTS  
Part 1 
Of 353 patients referred to the specialist memory clinic during the recruitment 
period and of 148 eligible to take part in this study, 36 declined to participate 
and 112 were enrolled (see Figure 1 CONSORT diagram). Three withdrew 
their consent subsequently, leaving 109 who completed the study. There were 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  11 
no significant differences in terms of age, gender, anxiety, depression or ACE-
R scores between those who consented to take part and those who did not, 
suggesting that the participants were representative of the wider population 
served by this memory clinic. There was also no significant difference in terms 
of diagnostic mix between people who consented and people who did not 
consent (see supplementary Table 1). The ND patient group (n=20) 
comprised of eight patients with AD, four with amnestic MCI, two with vascular 
dementia, two with frontotemporal dementia, three mixed AD and vascular 
and one unspecified dementia (without detailed neuropsychology). Figure 1 
also provides more information about participants who were excluded from 
the study. 
 
Clinical details of the patients included in the ND and FMD groups described 
here are provided in Table 2. Two participants out of the twenty with FMD had 
MRI brain scans reported as possible atrophy. They were both followed up; 
One followed up at 24 months was aware that they had been working in a 
very stressful job at time of the first consultation. At follow-up they had 
changed jobs and now had no memory complaints. The second person was 
followed up at 18 months. The Montreal Cognitive Assessment (MoCA) was 
26/30 at follow-up (prior ACE 85 and MoCA 22). They were functioning 
normally in a busy job. Two participants out of twenty cases with ND had 
normal structural scans but one of these had abnormal Single-Photon 
Emission Computed Tomography (SPECT). The other was seen for follow-up 
at 12 months and ACE-R had decreased from 87 to 82, the clinical picture at 
this stage being consistent with AD.  
 
In Part 2 of the study, three out of five FMD cases did not attend for 
neuropsychology testing, hence the missing MMSE scores in table 2. 
However, their ACE-R scores were 87, 96 and 97. Two had entirely normal 
neuroimaging and were discharged. One had an old caudate head infarct and 
on follow-up one year later was still working, managing a team. Repeat ACE-
R was 96 (97 one year earlier). Also in Part 2, one person with ND did not 
have detailed neuropsychological testing. Neuroimaging showed atrophy. On 
follow-up this patient showed significant cognitive impairment.  
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There were no significant differences in demographics, depression, anxiety or 
ACE-R scores between ND participants in Parts 1 and 2 or between FMD 
patients in the two parts of this study. 20 of the 30 participants included in Part 
1, and seven of ten included in Part 2 of this study were accompanied. 
)HDWXUHSDWLHQW¶VKHDGWXUQHQFRXUDJLQJDFFRPSDQ\LQJSHUVRQWRDQVZHU
a question directed at the patient) could not be rated in two of the 
accompanied encounters because participants had only consented to audio 
recording the interaction.  
 
Table 3 VKRZVWKHDQDO\VW¶V'6$UDWLQJVRIWKHLQWHUDFWLRQVLQFOXGHGLQPart 1 
of this study. A more detailed description of the individual items can be found 
on the DSA form (additional web content). The median total score of the first 
nine items of the DSA was +5 in the ND (range +8 to -3) and -5 in the FMD 
group (range 0 to -9, difference p<0.001). 
 
The median total of the five additional items to be rated in accompanied 
encounters was 2 (range +5 to -3) in the ND group and -1 (range 1 to -5) in 
the FMD group (difference p=0.003). The fact that only one of the additional 
items to be rated in accompanied encounters individually yielded a statistically 
significant between-group difference may (at least in part) be explained by the 
relatively small number of accompanied interactions available for analysis.  
 
In view of the fact that the additional item scores for accompanied interactions 
were only available for a subset of the encounters, only the first nine items 
were used for the AUROC analysis and the estimation of a quantitative 
diagnostic threshold. The area under the ROC curve was 0.98 (see Figure 2). 
At the optimal DSA score for the distinction of patients with ND from those 
with FMD of +1 (with DSA score above this threshold suggesting a diagnosis 
of ND) the DSA-derived total score identified patients with ND with a 
sensitivity of 86.7% and a specificity of 100%. 
 
3.4 RESULTS ± PART 2 
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3.4.1 Quantitative scoring using the DSA (blinded results) 
 
Rater 1 was accurate in 10/10 cases, whilst Rater 2 correctly predicted 9/10 
diagnoses on the basis of DSA-guided qualitative analysis (Rater 1 was more 
experienced because of his involvement in Part 1 of the project). The results 
were identical when the linguistic diagnostic prediction was based on the 
numeric DSA scores. The case misdiagnosed by Rater 2 as FMD (when the 
ultimate medical diagnosis was ND) attracted the lowest score Rater 1 gave 
to any of the patients assessed as having ND (+4) and the highest score 
Rater 2 gave to any patients thought to have FMD (-1). This suggests that the 
patient misdiagnosed by Rater 2 had an objectively ambiguous conversational 
profile, posing a particular discriminatory challenge. The differences in the two 
UDWHUV¶GLDJQRVWLFSUHGLFWLRQZDVEDVHGRQDVLQJOHFRPSOHWHO\GLVFRUGDQW
judgment of DSA item 4 (ratings 1 vs. -1) and on non-concordant decisions (0 
vs. 1 or 0 vs. -1) on DSA items 3, 7, 9, 13 and 14 (see Table 4 for further DSA 
scoring details).  
 
 
3.4.2 Inter-rater reliability of the DSA 
 
,QWHUPVRIWKHILQDOGLDJQRVLVHLWKHUEDVHGRQWKHWZRUDWHUV¶TXDOLWDWLYH
judgements or the quantitative procedure using the diagnostic cut-off derived 
from the AUROC analysis), the raters agreed in 9/10 cases. The Kappa value 
for the DSA procedure as a whole was therefore 0.8 (SE of Kappa = 0.19, 
95% confidence interval 0.44 to 1.0) suggesting 'very good' inter-rater 
reliability. We also looked at the inter-rater reliability of the 123 individual +1, 0 
or -1 ratings from Part 2 of this study. Both ratings were fully concordant for 
87 numeric scores (the scores from raters 1 and 2 were 1/1, 0/0 or -1/-1), non-
concordant for 30 and discordant for 6. This means that both raters agreed on 
70.7% of the observations when agreement on 33.8% of the ratings would 
have been expected by chance.  The Kappa value for all 123 DSA-based 
ratings combined was 0.56 (SE of Kappa = 0.06, 95% confidence interval 
0.44 to 0.68), consistent with 'moderate' inter-UDWHUDJUHHPHQW7KHWZRUDWHUV¶
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scores for each item assessed in part 2 of the study and the Kappa-values of 
each individual item are shown in table 3. 
 
Discussion 
Our previous qualitative work has demonstrated that it is possible to describe 
characteristic conversational profiles of patients describing cognitive problems 
due to ND or FMD based on their interactional and linguistic contributions to 
initial encounters in a memory clinic20, 21. However, in these descriptive 
studies, the conversation analysts who analysed video- and audio recordings 
of memory clinic encounters between neurologists, patients and (sometimes) 
accompanying persons were DOZD\VDZDUHRIWKHSDWLHQWV¶PHdical diagnoses 
during the analytic process. The present study is the first to demonstrate that 
these linguistic and interactional features can be used diagnostically to predict 
diagnoses of ND or FMD made on the basis of standard medical criteria. 
What is more, we show that qualitative assessments can be structured and 
likely medical diagnoses formulated using a Diagnostic Scoring Aid with a 
numeric diagnostic cut-off.  The fact that the linguistic raters involved in this 
study had no expertise in the medical assessment of patients presenting with 
memory problems, together with the relatively high level of agreement 
between the two raters, suggests that the raters did not base their diagnostic 
predictions on an ill-defined hunch but on robust and objectifiable interactional 
observations. 
  
The correct classification of 9/10 by one rater and 10/10 by a second 
independent rater, and the very good inter-rater reliability of the DSA-guided 
procedure as a whole, suggest that the addition of the structured observation 
of interactional features can make a significant contribution to screening 
processes for ND. Importantly, this is one of the few studies of cognitive 
VFUHHQLQJµWRROV¶WRLQFOXGHSDUWLFLSDQWVZLWK)0D; most previous studies 
compared patients with memory impairment with healthy controls. The 
inclusion of a group of patients with memory complaints but no neurological 
disorder adds ecological validity to our findings. Compared to other studies 
set in clinical situations (such as a study exploring the screening potential of 
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the 6CIT brief cognitive test in primary care) our approach appears to have 
greater reliability and validity 9. 
 
Interactional and linguistic observations may increase the confidence of non-
expert clinicians to diagnose clear cases of FMD, enabling them to treat 
patients in primary care or to refer them on to services providing appropriate 
treatment for functional neurological disorders.  Importantly, the interactional 
and linguistic observations contributing to the diagnosis of FMD may allow 
clinicians to provide more effective reassurance by allowing them to 
demonstrate to patients that they are displaying good memory function in 
interaction. It should be possible for clinicians to pick up these features during 
routine clinic encounters. Previous studies in patients presenting with epileptic 
or dissociative (non-epileptic) seizures have demonstrated that doctors can 
learn to change their history-WDNLQJVW\OHWRRSWLPLVHSDWLHQWV¶RSSRUWXQLWLHVWR
demonstrate particular conversational behaviours and to make diagnostically 
useful interactional observations as they take a paWLHQW¶VKLVWRU\41. The DSA 
developed here could be modified and used in similar studies investigating 
whether clinicians can be trained to identify features, which have diagnostic 
value while talking to patients with memory problems.  
 
This study has a number of limitations. First and foremost, we were only able 
to explore the potential of CA as a tool capable of predicting medical 
diagnoses in the setting of initial memory clinic encounters in a modest 
number of patients. Whilst the consecutive recruitment and the levels of 
statistical significance in between-group tests on a range of separate 
conversational features observed even in such a small patient group make it 
unlikely that our findings are spurious, it would be desirable to replicate our 
findings in a larger and more diverse group of patients. One particular 
limitation of our findings in this regard is that we excluded patients with 
depression and those with VCI from this first quantitative study of our method. 
These are important differential diagnoses, which will need to be picked up by 
screening procedures. Future larger studies will need to demonstrate that the 
inclusion of interactional and linguistic observations can contribute to 
screening or stratification procedures in which patients with these problems 
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are allocated to the correct management pathways. We also recognised that 
the ND and FMD groups in this study were not age-matched since those with 
ND were significantly older. This is not surprising as the biggest risk factor for 
ND is increasing age. However as younger patients with memory concerns 
are increasingly referred to specialist memory clinics it is important to include 
and compare all age groups in studies of this nature. Furthermore the mean 
MMSE score of the ND group was lower than that of the FMD group (20.4 
versus 28.2), reflecting the relatively late stage in the development of 
cognitive disorders at which patients are currently first referred to specialist 
services. Only four of the patients in the ND groups had MCI. An optimal 
screening tool for the earliest stages of ND would need to be capable of 
picking up patients with MCI and near normal MMSE scores). This means that 
confirmatory studies capturing more patients at an earlier stage of ND will be 
required before the method described here can be embedded in screening 
procedures. The MMSE scores of the MCI patients included in this study were 
just above the standard cut-off score of 23 for this test, indicating that, 
although unimpaired in their activities of daily living, they already had 
extensive global cognitive impairment. We do not know how effective this tool 
will be at distinguishing MCI from FMD. Because a clinical diagnosis of MCI 
refers to a very heterogeneous symptom profile, the distinction between MCI 
and FMD might be difficult and will require larger number of participants, 
along with prospective follow-up to investigate whether it can predict those 
who are at high risk of developing AD or other dementias. 
 
 
We have only studied native English speakers; findings may have been 
different in patients speaking other languages or those using English as a 
second language. Although several different doctors were involved in the 
clinic conversations studied here, it would also be important to test this 
procedure in different clinical settings (for instance in community-based 
clinics, during home visits and in elderly-care settings). The fact that the ND 
group included patients with memory problems of different aetiologies should 
not be considered a weakness of this study. Although it is likely the method 
employed in this study could also be deployed to identify interactional 
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differences between different ND VXFKDV$O]KHLPHU¶VGLVHDVHRU
frontotemporal dementia) the fact that we were able to distinguish clearly 
between patients with a range of ND and those with FMD demonstrates its 
potential for screening or stratifying patient management.  
 
We did not have access to investigations confirming clinical diagnosis with 
tests documenting the presence of amyloid or tau (PET or cerebrospinal 
studies), but this reflects current NICE guidelines 
(http://www.nice.org.uk/guidance/CG42) and our µPHGLFDO¶diagnoses were 
based on multidisciplinary assessment by experts including detailed 
neuropsychological testing and structural brain imaging as well as clinical 
follow up.  
 
Future studies will need to demonstrate how much diagnostic value the 
observation of interactional features can add to conventional brief cognitive 
screening tools. A combined approach with an automated low cost, high-
speed system to analyse speech will require the use of technology rather than 
Conversation Analysts. One way in which the research described here can be 
taken forward involves the computerised analysis of speech which has shown 
some promise in distinguishing AD, MCI and healthy controls16. Early 
indications are that computerised speech analysis and machine learning 
algorithms can also be used to produce an automated system to pick up and 
evaluate the sort of interactional observations described here and can 
discriminate between ND and FMD 22. 
 
More immediately, the findings described here can be used in the training of 
clinicians working with patients with memory problems.  
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Figure 1. CONSORT diagram showing recruitment to study. FMD- Functional 
Memory Disorder; DPD- Depressive Pseudo Dementia; ND- memory 
problems secondary to neurological disorders (ND) ± this includes 
neurodegenerative dementias and mild cognitive impairment due to likely 
underlying neurodegenerative aetiology. 
 
Figure 2: Area under the Receiver Operator Characteristic Curve  
A ROC curve was constructed for the sample of 15 ND and 15 FMD cases. 
 
Table 1 Diagnostic Scoring Aid (DSA) 
For each interactional feature scores range between 1 and -1 (1: in favour of 
ND; 0: undecided or unable to rate; -1: in favour of FMD). There are 9/14 
(unaccompanied/accompanied) items to score, so the maximum score is 9/14 
(unaccompanied/accompanied) and minimum score -9/-14 
(unaccompanied/accompanied). A high score corresponds to a stereotypical 
ND description; a low score to a stereotypical FMD description. 
 
Supplementary Table 1 Comparison of patients eligible for participation in 
the study who did and did not consent to have their clinic interaction recorded 
and analysed. 
 
There is no significant difference in demographics or test scores between the 
SHRSOHZKRFRQVHQWHGDQGWKHSHRSOHZKRGLGQRWFRQVHQW$GGHQEURRNH¶V
Cognitive Examination; Patient Health Questionnaire-9 PHQ9- Generalised 
Anxiety Disorder scale 7 GAD7 
 
Table 2 Demographic and neuropsychological results 
ACE-5$GGHQEURRNH¶V&RJQLWLYH([DPLQDWLRQ006(0LQL0HQWDO6WDWH
Examination. PHQ9- Patient Health Questionnaire 9 item depression scale. 
GAD7General Anxiety Disorder 7-item Scale  CF- Confrontational Naming. 
VPA- Verbal Paired Associates, P&PT-3\UDPLG	3DOP7UHHV5H\¶V&)- 
Rey's Complex Figure, SF- Semantic Fluency, PF - Phonemic Fluency, DS -
Digit Span, VCA- Visuoconstructive Apraxia, TT-Token task, PM - Prose 
Memory. * 3 missing scores. + 1 missing score. # 
Three missing scores from ND group (2 due to different protocol and one 
participants from part 2). Three missing scores from FMD group due to not 
attending appointments. Twenty participants with ND; comprised eight with 
AD, four with amnestic MCI, two 2 with vascular dementia, two with fronto 
temporal dementia, three with mixed AD and vascular and one unspecified 
dementia (without detailed neuropsychology).  
 
 
Table 3: Diagnostic Scoring Aid (DSA) results 
Profiles of 30 patients attending a specialist clinic with memory secondary to 
neurological disorders (ND) ± this includes neurodegenerative dementias and 
mild cognitive impairment due to likely underlying neurodegenerative 
aetiology or functional memory disorder (FMD).  3a: Items rated in all 
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encounters / 3b: Items only rated in encounters also involving an 
accompanying person (AP). 
For a full description of the items see supplementary appendix. Some items 
were unratable because a particular question was nRWDVNHGHJ³ZKRLVPRVW
FRQFHUQHG"´ 
 
 
Table 4 Diagnostic Scoring Aid (DSA) results of blinded analysis. 
Two independent linguistic raters (L1 and L2) of interactions with five patients 
with a medical diagnosis of FMD (5a) and five patients with medical diagnosis 
of ND (5b). 
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Differential Diagnosis Scoring Table 
This scoring table was developed to assist in the differential diagnosis of patients 
with neurodegenerative diseases (ND) (e.g. Alzheimer's disease, other type of 
dementia and mild cognitive impairment) and those with functional memory disorder 
(FMD) (i.e. memory problems with a non-organic cause). Many of the features 
included in this scoring chart have been documented in the following sources: 
x Conversational assessment in memory clinic encounters: interactional 
profiling for the differential diagnosis of dementia and functional memory 
disorder. Danielle Jones, Chris Elsey, Daniel Blackburn, Sarah Wakefield, 
Kirtsy Harkness, Annalena Venneri, Paul Drew, Markus Reuber. Ageing and 
Mental Health. 2015 1-10. 
x Towards a diagnostic conversational profile of dementia within memory 
clinics. Chris Elsey, Paul Drew, Danielle Jones, Daniel Blackburn & Markus 
Reuber. Patient Educ Couns. 2015, 98(9), 1071-7. 
 
Scores range between 1 and -1 (1: in favour of ND; 0: undecided or unable to rate; -
1: in favour of FMD). There are 9/14 (unaccompanied/accompanied) items to score, 
so the maximum score is 9/14 (unaccompanied/accompanied) and minimum score -
9/-14 (unaccompanied/accompanied). A high score corresponds to a stereotypical 
ND description; a low score to a stereotypical FMD description. 
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1. Configuration of interaction 
Neurologist-patient 
Neurologist-patient-accompanying persons 
 
1. Is the patient accompanied? 
 
Description of relevant evidence 
 
 
 
Yes 1 Score 
N/A 0 
No -1 
 
Instructions 
This item simply records whether the patient is accompanied for their visit to the 
memory clinic. This can include family members, friends, carers and the like.  
Patients with ND are more likely to be accompanied to the consultation, whereas 
those with FMD are generally more independent and likely to come alone.. 
 
 
 
 
 
 
2. Responding to neurologists' specific questions about memory 
problems 
2. Specific question - "Who is most concerned about the memory problems?" 
The neurologists in the study were instructed to ask a selection of pre-designed 
questions in order to aid comparison of the patients¶ responses. The purpose of this 
question is to gauge who is aware of and concerned about the reported memory 
complaints. 
Description of relevant evidence 
 
 
 
AP states they are most concerned, patient no reply or "I don't 
know". 
1 Score 
Question (or equivalent) not asked, or mixed answer 0 
"It's me" "I am" -1 
 
Instructions 
When responding to this question the FMD tended to state that they were the person 
most concerned about the memory issues ("[It's] me"). For the ND a different set of 
responses occurred. Either, the AP offers they own opinion claiming they are most 
concerned (responsible for appointments, awareness issues); or the patient 
struggles to respond to this question sometimes failing to answer at all or saying "I 
don't know".  
 
 
 
 
3. Specific question - "Can you give me an example of the last time your 
memory let you down?" 
The purpose of this question is to gauge whether patients can offer specific and 
detailed accounts of a recent memory trouble. This question has a few variations or 
equivalents in which the neurologist might ask for the "a/most recent" example or 
provide a time frame "last week/month") 
Description of relevant evidence 
 
 
 
 
 
 
 
Patient provides no response, a partial/incomplete answer or 
offer a general/routine problem (e.g. daily") 
1 Score 
 0 
Patient provides a detailed and specific response about a 
recent occurrence 
-1 
 
Instructions 
If the patient successfully provides a relevant and detailed example of a particular 
recent event, it is more likely that they have FMD.  
In contrast, ND patients will either make no response, or hesitate over the 
beginnings of a response (e.g., "um" or "er"), or declare that they were unable to 
remember a specific occasion. These patients might offer an 'example', however, it 
will consist of a routine or common problem, rather than a specific incident (e.g., 
"happens all the time" or "it's daily"). 
 
 
3. Working and episodic memory exhibited within the present consultation 
 
4. Ability to recall to recent episodic memory during interaction 
Patient displays ability to recall previously mentioned or talked-about information 
from within the consultation itself.  
Description of relevant evidence 
 
 
 
 
 
 
 
No 1 Score 
 0 
Yes (e.g. "Like I said", "as I said") -1 
 
Instructions 
Patients with FMD not only display intact episodic memory in relation to what the 
other (neurologist or AP) has said in the consultation, but also when recalling and 
repeating information they have previously voiced themselves (e.g. "Like I said", "as I 
said"). In contrast those with ND are often unable to display memory in this way in 
their consultations. They are often unable to retain information about what has been 
said even a few seconds earlier in the interaction, either by themselves or by the 
neurologist. 
Note for this purpose compound questions are excluded, as they form a separate 
interactional feature. 
 
 
5. Responding to compound questions 
Exploring how patients respond to question with multiple-parts (e.g. Do you know the 
reasons why you've been referred to this clinic and, and who's more concerned?"). 
Description of relevant evidence 
 
 
 
 
 
 
 
Unable to attend to different parts of compound questions 1 Score 
 0 
Can attend to different parts of compound questions  -1 
 
Instructions 
FMD patients are more likely to be able to respond attend to multiple parts of a 
question and return to them even after extended turns at talk. In contrast, ND 
patients experience more difficulties responding to such question formulations, 
frequently replying to single components of the compound questions; they are less 
likely to be able to recall and respond to other aspects of the original question, 
resulting in the neurologist having to repeat the omitted parts of the question. 
 
 
 
 
 
 
4. How patients respond to neurologists' questions and 
communication difficulties exhibited 
 
6. Prevalence of "I don't know" responses (excluding head-turning sign) 
Description of relevant evidence 
 
 
 
 
 
 
 
Recall based problems 1 Score 
 0 
New questions, not previously considered -1 
 
Instructions 
FMD patients generally respond verbally with "I don't know" only rarely and these are 
linked to questions that elicit their "expectations" for the visit. These patients exhibit 
uncertainty that suggests that they have not previously considered the matter asked 
about and were unsure of the answer. In short the problem is not suggestive of a 
recall issue. 
In contrast for ND patients these utterances occur throughout the consultation. 
These utterances may take a verbal form of "I don't know" or equivalent phrases.  
 
 
 
 
7. Patients' elaborations and length of turns at talk 
Description of relevant evidence 
 
 
 
 
 
 
 
Short, 'literal' answers 1 Score 
 0 
Long responses, that provide extra detail -1 
 
Instructions 
FMD patients are more likely to volunteer unsolicited details (going beyond the 
parameter of the original question) that give additional, appropriate, relevant and 
related information ± in short, they elaborate their responses. ND patients tend to 
offer answers that are brief, and restricted to the parameters of original questions.  
 
 
 
 
 
 
 
 
 
8. Repetition 
Description of relevant evidence 
 
 
 
 
 
 
 
More 1 Score 
 0 
Less -1 
 
Instructions  
ND more prone to repetition of own words and those of others without marking it as 
such. 
 
 
 
 
 
 
 
 
 
 
 
9. Production of talk  
Focusing particularly on whether a patient is able to reply promptly to neurologists¶ 
questions.  
Description of relevant evidence 
 
 
 
 
 
 
 
Struggle to reply to questions, communication difficulties 1 Score 
 0 
Able to provide answers when asked,  -1 
 
Instructions  
In general the speech production of FMD patients is close to that seen in ordinary 
conversation. These patients display fewer speech production difficulties and are 
also more likely to give extended/expanded responses. Disfluent talk characterised 
by long pauses, delayed responses, hesitation, self-interrupts (staccato-like), 
repetition (of word from self and others), incomplete, aborted or unfinished 
utterances. 
 
 
 
 
 
 
5. Triadic features  
These should only be scored for consultations in which an AP is 
present throughout 
 
10. If the patient is accompanied, what is the main interactional 
contribution/role of the accompanying persons (AP)? 
Description of relevant evidence 
 
 
 
 
 
 
 
 
AP acts as patient's representative or spokesperson 1 Score 
N/A 0 
AP role limited to confirmation checks and second opinions -1 
 
Instructions 
This item relates to the amount and type of contributions offered by AP (if they are 
present). If the AP speaks throughout the consultation, frequently augmenting the 
patient's responses and providing specific/detailed examples of problems the patient 
is more likely to have an ND diagnosis. In contrast, for FMD the AP often has a more 
restricted role in the interaction, which tends to be limited to providing 'confirmation 
checks' to a patient¶s answers or at a designated point of the consultation the 
neurologist might specifically engage the AP to seek a second opinion about the 
memory problems raised. 
 
11. Presence of head-turning sign (excluding verbal "I don't know" replies) 
Description of relevant evidence 
 
 
 
 
 
 
 
Patient defers answering to AP by turning to them 1 Score 
 0 
Able to answer most questions, turn for confirmation only -1 
 
Instructions 
When a patient with ND is struggling to answer they might physically turn to an AP (if 
present). This non-verbal/embodied display defers or passes the responsibility of 
responding to the AP (implicitly suggesting an "I don't know" response). This is called 
a 'head-turning sign'. In contrast patients with FMD are less likely to respond to 
questions in this way as fewer of the neurologists questions cause such difficulties (if 
an AP is present). 
This feature excludes verbal "I don't know" replies (see feature 6 above). 
 
 
 
 
 
 
 
12. Disagreements and discrepancy between patient responses and AP 
Description of relevant evidence 
 
 
 
 
 
 
 
Yes 1 Score 
 0 
No -1 
 
Instructions 
If an AP is present is there evidence of disagreement sequences? For comparative 
purposes these sequences should take the following format: 
x Question by neurologist which seeks a yes/no response (e.g. do you cook at 
home) 
x Answer from the patient matching the yes/no requirements of the question 
(e.g. "yes"). Often the patient's response indicates the content of the question 
is "no problem" for them. 
x The third turn in the sequence will involve the AP contradicting or correcting 
the patient's reply ("No, you used to/you don't do that anymore" etc) 
x The patient then adjusts their original response (e.g. "no" or "that's true" etc) 
In terms of identifying this pattern it is more common in interactions involving patients 
with ND diagnoses, than those with FMD. 
 
 
 
13. Word searches  
Description of relevant evidence 
 
 
 
 
 
 
 
Display 'word search' difficulties during consultation, AP 
provide 'missing' information 
1 Score 
 0 
Report 'word search' difficulties in the past -1 
 
Instructions  
The item refers to a particular type of memory complaint. This feature is often 
mentioned as a sign of the memory problems the patient with FMD has noticed 
previously (reported memory complaints), whereas the ND patients 'display' this type 
of memory problem during the course of the consultation itself and might seek the 
assistance of an AP to fill in the blank. 
 
 
 
 
 
 
 
 
14. Responding to personal questions  
This refers to patients' abilities to respond to non-test questions in which the answer 
is unknown or generally unavailable to the neurologist (including age, education, 
work details, marital history etc). 
Description of relevant evidence 
 
 
 
 
 
 
 
Evidence of difficulties answering these questions 1 Score 
 0 
Can answer these questions relatively easily -1 
Instructions  
These questions are more likely to cause difficulties for ND patients, who might be 
unable to recall the salient details required. As such they might require the help of 
AP or be corrected by them. FMD find these questions more straightforward. 
 
Diagnostic feature More suggestive of  
Dementia 
 
Score: +1 
More suggestive of functional memory 
problems 
 
Score: -1 
Score 
 
(0: if 
uncertain) 
Who attends the memory clinic?  1, 0 or -1 
1. Is the patient 
accompanied? 
Yes (Accompanied persons (AP) 
include family or friends) 
No  
Responding to neurologists' specific questions about memory problems  
2. "Who is most 
concerned about the 
memory problems?" 
No reply from patient, "I don't know" or 
AP states they are most concerned 
The patient.  
3. "Can you give me an 
example of the last time 
your memory let you 
down?" 
No response, partial or incomplete 
answer, or offer a routine common 
problem (it's daily") 
Provides detailed specific example  
Working and episodic memory exhibited within the present consultationWorking memory exhibited 
within the present consultation 
 
4. Ability to recall to 
recent episodic memory 
during 
interactionWorking 
memory in interaction 
Not demonstrated Repetitions marked by phrases such as 
"Like I said" or "as I said" 
 
5. Responding to 
compound questions 
Unable to attend to different parts of 
compound questions 
Can attend to different parts of compound 
questions 
 
How patients respond to neurologists' questions  
6. Prevalence of verbal 
"I don't know" 
responses 
Frequent  Infrequent, relate to new issues not 
previously considered 
 
7. Patients' 
elaborations and length 
of turns at talk 
Short, literal answers Long responses, sharing of additional, 
unsolicited details 
 
8. Repetition More frequent repetition of own and 
others' utterances 
Less frequent, marked as repetitions  
9. Production of talk Struggle to reply to questions, 
communication difficulties 
Able to reply when questioned   
Features to rate if patient accompanied  
10. What is the main AP acts as patient's representative or AP role limited to confirming information as  
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role of the 
accompanying persons 
(AP)? 
spokesperson accurate and offering second opinions 
11. Presence of head-
turning sign (embodied 
"I don't know") 
When struggling to answer question 
patient turns to AP and defers the 
answer to them 
Can answer most questions by themselves  
12. Disagreements AP's interject to disconfirm and correct 
the accuracy of the patient's 
responses. Frequent. 
Limited evidence of explicit disagreements 
between patient and AP 
 
13. Word searches Display 'word search' difficulties during 
consultation, AP provide 'missing' 
information 
Report 'word search' difficulties in the past  
14. Responding to 
personal questions 
Evidence of difficulties answering 
these questions, requiring help from 
AP to fill in blanks.  
Can answer these questions relatively 
easily and with little hesitation 
 
Total score 
   
 
 
  ΦΜD (ν=20) ΝD (ν=20) Νορmατιϖε 
Μεαν 
Χυτ Οφφ Π ϖαλυε 
Αγε 57.25 (+/−1.82) 64.2 (+/− 2.13) 
 
  π=0.0018 
 
Φεmαλε 60% 60%   ν/σ 
ΑΧΕ−Ρ 92.47 (+/−1.18) 65.53 (+/− 4.78)  88 π<0.0001 
 
ΜΜΣΕ 28.88 (+/−0.19)∗ 
 
20.44 (+/− 1.71)+ 
 
28.88 (1.28) 
 
26.32 
 
π<0.0001 
 
ΠΗΘ9 5.68 (0.96) 
 
4.47 (+/− 1.67) 
 
 5 
 
π=0.51 
 
ΓΑD7 4.84 (+/− 1.04) 
 
4.47 (+/− 1.23) 
 
 5 π=0.82 
 
ΧΦ 19.82 (+/− 0.1)# 
 
17.59 (+/− 0.73) # 
 
19.65 (0.63) 
 
18.39 
 
π=0.0049 
 
ςΠΑ 16.76 (+/− 0.68) # 
 
6.88 (+/− 1.14.) # 
 
14.81 (3.76) 
 
7.29 
 
π<0.0001 
 
Π&ΠΤ 51.18 (+/− 0.18) # 
 
45.81 (+/− 1.94) # 
 
51.23 (0.82) 
 
49.59 
 
π=0.0793 
 
Ρεψ∋σ 
ΧΦ 
33.165 (+/−0.45) # 
 
23.75 (+/− 2.52) # 
 
33.70 (2.30) 
 
29.1 
 
π<0.0004 
 
ΣΦ 50.94 (+/− 3.21) # 
 
28.82 (+/− 4.09) # 
 
59.81 (13.17) 
 
33.47 
 
π<0.0002 
 
ΠΦ 40.47 (+/− 2.79) # 
 
22.25 (+/− 3.86) # 
 
45.58 (12.05) 
 
21.48 
 
π<0.0005 
 
Dιγιτ 
Σπαν 
6.65 (+/− 0.3) # 
 
5.06 (+/− 0.47) # 
 
6.76 (1.48) 
 
3.8 
 
π=0.0071 
 
ςΧΑ 13.24 (+/− 0.18) # 
 
10.65 (+/− 0.79) # 
 
13.77 (0.51) 
 
12.75 
 
π=0.0032 
 
ΤΤ 34.82 (+/− 0.28) # 
 
28.0 (+/− 1.62) # 
 
34.67 
 
1.03 
 
π<0.0002 
 
ΠΜ 14.65 (+/− 0.87) # 
 
5.5 (+/− 0.9) # 
 
  π<0.0001 
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 Ταβλε 3α 
Ιτεm Dεσχριπτιον∗ Α: Τψπιχαλ οφ ΝDD Β: Τψπιχαλ οφ ΦΜD Νυmβερ οφ 
ΝDD  χασεσ 
χατεγοριζεδ 
Α/Β∗∗ 
(ν=15) 
Νυmβερ οφ 
ΦΜD χασεσ 
χατεγοριζεδ 
Α/Β∗∗ 
(ν=15) 
Dιφφερενχε 
ΝDD 
ϖερσυσ 
ΦΜD  
(π−ϖαλυε) 
1 Ισ τηε πατιεντ 
αχχοmπανιεδ 
Ψεσ Νο 14/1 6/9 π=0.003 
2 Wηο ισ mοστ χονχερνεδ? Οτηερσ Πατιεντ τηεmσελϖεσ 6/1 0/9 π=0.0008 
3 Σπεχιφιχ εξαmπλε οφ 
mεmορψ φαιλυρε 
Νο ορ παρτιαλ / ινχοmπλετε 
ανσωερ ορ οφφερσ α γενεραλ / 
ρουτινε προβλεm  
Dεταιλεδ ανδ σπεχιφιχ 
ρεσπονσε αβουτ α ρεχεντ 
οχχυρρενχε 
11/0 
 
1/11 
 
π<0.0001 
4 Ability to recall recent 
episodic memory during 
interactionWορκινγ 
mεmορψ ιν ιντεραχτιον 
Πατιεντ υναβλε το ρεχαλλ 
εαρλιερ ταλκ 
Πατιεντ αβλε το ρεχαλλ 
εαρλιερ ταλκ (∀Λικε Ι σαιδ∀) 
11/3 
 
0/8 
 
π=0.001 
5 Ρεσπονδινγ το 
χοmπουνδ θυεστιονσ 
Υναβλε το αττενδ το διφφερεντ 
παρτσ οφ χοmπουνδ 
θυεστιονσ 
Χαν αττενδ το διφφερεντ 
παρτσ οφ χοmπουνδ 
θυεστιονσ 
7/1 
 
3/7 
 
π=0.02 
6 Πρεϖαλενχε οφ ∀Ι δον∋τ 
κνοω∀ ϖερβαλ ρεσπονσεσ 
Ινδιχατεσ ρεχαλλ−βασεδ 
προβλεmσ 
Ρεσπονσε το υνεξπεχτεδ 
θυεστιονσ  
11/1 
 
1/14 π<0.0001 
7 Πατιεντσ∋ ελαβορατιονσ 
ανδ λενγτη οφ τυρνσ  
Σηορτ, ∋λιτεραλ∋ ανσωερσ Λονγ ρεσπονσεσ, τηατ 
προϖιδε εξτρα δεταιλ 
9/6 0/11 
 
π=0.002 
8 Ρεπετιτιον Μορε φρεθυεντ Λεσσ φρεθυεντ 10/3 1/11 π=0.001 
9 Προδυχτιον οφ ταλκ Στρυγγλε το ρεπλψ το 
θυεστιονσ, χοmmυνιχατιον 
διφφιχυλτιεσ 
Αβλε το προϖιδε ανσωερσ 
ωηεν ασκεδ 
7/2 
 
1/13 
 
π=0.001 
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Ταβλε 3β 
Ιτεm Dεσχριπτιον∗ Α: Τψπιχαλ οφ ΝDD Β: Τψπιχαλ οφ ΦΜD Νυmβερ οφ 
ΝDD  χασεσ 
χατεγοριζεδ 
Α/Β∗∗ 
(ν=14) 
Νυmβερ οφ 
ΦΜD χασεσ 
χατεγοριζεδ 
Α/Β∗∗ 
(ν=6) 
Dιφφερενχε 
ΝDD 
ϖερσυσ 
ΦΜD  
(π−ϖαλυε) 
10 Μαιν ιντεραχτιοναλ 
χοντριβυτιον/ρολε οφ τηε 
ΑΠ  
ΑΠ αχτσ ασ πατιεντ∋σ 
ρεπρεσεντατιϖε ορ 
σποκεσπερσον 
ΑΠǯ ρολε λιmιτεδ το 
χονφιρmατιον χηεχκσ ανδ 
σεχονδ οπινιονσ 
9/1 
 
 
1/5 
ν = 6 
π=0.008 
11 Πρεσενχε οφ ηεαδ−
τυρνινγ σιγν (εξχλυδινγ 
ϖερβαλ ∀Ι δον∋τ κνοω∀ 
ρεπλιεσ) 
Πατιεντ δεφερσ ανσωερινγ το 
ΑΠ βψ τυρνινγ το τηεm 
Αβλε το ανσωερ mοστ 
θυεστιονσ, τυρν φορ 
χονφιρmατιον ονλψ 
10/4 
 
3/3 
 
ν. σ.  
12 Dισαγρεεmεντσ βετωεεν 
πατιεντ ανδ ΑΠ 
Πρεσεντ Νοτ πρεσεντ 13/1 
 
2/4 
 
ν. σ.  
13 Wορδ σεαρχηεσ Dισπλαψσ ∋ωορδ σεαρχη∋ 
διφφιχυλτιεσ δυρινγ 
χονσυλτατιον, ΑΠ προϖιδεσ 
∋mισσινγ∋ ινφορmατιον 
Ρεπορτ ∋ωορδ σεαρχη∋ 
διφφιχυλτιεσ ιν τηε παστ βυτ Ǯǯ 
3/1 
 
3/3 
 
ν. σ.  
14 Ρεσπονδινγ το περσοναλ 
θυεστιονσ  
Εϖιδενχε οφ διφφιχυλτιεσ 
ανσωερινγ τηεσε θυεστιονσ 
Χαν ανσωερ τηεσε 
θυεστιονσ ρελατιϖελψ εασιλψ 
6/5 
 
0/6 
 
ν. σ. 
 
 4α: Πατιεντσ ωιτη mεδιχαλ διαγνοσισ οφ ΦΜD 
Πατιεντ Νο. 
 
1 2 3 4 5 
DΣΑ Ρατινγ 
σχορε 
Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 
1 −1 −1 −1 −1 1 1 1 1 −1 −1 
2 −1 −1 −1 0 0 0 0 0 −1 0 
3 −1 −1 −1 −1 0 0 −1 −1 −1 −1 
4 0 0 −1 −1 −1 0 −1 −1 −1 −1 
5 0 −1 0 0 0 −1 −1 −1 0 0 
6 0 −1 1 0 0 0 −1 0 −1 0 
7 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 
8 −1 −1 0 −1 −1 −1 −1 0 0 −1 
9 0 −1 −1 −1 −1 −1 0 −1 −1 −1 
10     −1 −1 −1 0   
11     −1 −1 −1 0   
12     1 −1 −1 1   
13     0 0 −1 −1   
14     −1 −1 −1 −1   
ΤΟΤΑΛ −5 −8 −5 −6 −5 −7 −10 −5 −7 −6 
Πρεδιχτεδ 
Dξ 
 
ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD 
Αχτυαλ DΞ ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD ΦΜD 
           
 
 
4β: Πατιεντσ ωιτη α mεδιχαλ διαγνοσισ οφ ΝD 
 
Πατιεντ 
Νο. 
 
1 2 3 4 5 
DΣΑ 
Ρατινγ 
σχορε 
Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 Λ1 Λ2 
1 1 1 1 1 1 1 1 1 1 1 
2 0 0 0 0 −1 0 0 0 1 1 
3 1 0 1 1 1 1 1 0 1 1 
4 1 −1 0 0 1 1 0 0 1 1 
5 −1 −1 0 0 0 1 1 1 1 1 
6 1 1 −1 0 1 1 1 1 1 1 
7 0 −1 1 1 1 1 1 1 1 1 
8 0 0 0 0 1 −1 1 0 1 1 
9 0 −1 1 1 1 1 1 1 0 1 
10 1 1 0 0 −1 −1 1 0 1 1 
11 −1 −1 1 1 0 0 Αυδιο Αυδιο 1 1 
12 1 1 1 1 −1 −1 −1 1 1 1 
13 0 1 1 −1 1 − 0 0 0 0 
14 0 1 −1 −1 1 1 1 1 0 1 
ΤΟΤΑΛ 4 −1 5 4 6 5 8 7 11 13 
Πρεδιχτεδ 
Dξ 
 
ΝD ΦΜD ΝD ΝD ΝD ΝD ΝD ΝD ΝD ΝD 
Αχτυαλ DΞ ΝD ΝD ΝD ΝD ΝD ΝD ΝD ΝD ΝD ΝD 
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